November 22nd 2024
These findings further suggest the implications of acne vulgaris treatment on the skin barrier.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
August clinical considerations for NPs and PAs
August 16th 2017In this month’s Clinical Considerations, we learn from a new study that laser treatment following isotretinoin therapy can possibly be initiated sooner than we thought; researchers have shown microwave technology may reduce underarm odor, and glean guidance for diagnosing mycosis fungoides.
Isotretinoin study: Laser treatment safe one month post-treatment
July 17th 2017A pilot study has successfully challenged the current non-evidenced medical recommendation that patients with acne scars should wait six to 12 months after completion of oral isotretinoin treatment before the safe initiation of nonablative fractional laser resurfacing.
Office-based alternative to in-home oral and topical regimen
May 10th 2017Application of a topical photoparticle immediately before non-ablative 810 nm diode laser treatment for acne resulted in a statistically significant reduction from baseline in inflammatory acne counts on the back, according to a small feasibility study.
Cumulative dosing of isotretinoin should not follow strict range
October 24th 2016Cumulative dosing of isotretinoin has followed a reference range of 120 to 150 mg/kg, but there is an absence of strong evidence supporting this recommendation, pointing to the need for clinicians to treat their patients to achieve clearance of acne rather than adhere to this range.